Quick Research
Filters Clear All
Any Time
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Cell Culture Medium
- Cell Culture Reagent
- Cell Function Assay
- Cell Health Detection Kit
- Cell Line
- Others
- Primary Cell
- Serum
- Service
- Transfection Reagent
Country
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Iran
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Korea
- Kuwait
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 25,274 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
Pan-cancer analysis identifies PD-L2 as a tumor promotor in the tumor microenvironment (2023-03-16)
Journal: Frontiers in Immunology (2023) IF: 7.3Products Cited: MC38 Cells Line -
Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data (2023-01-30)
Journal: Frontiers in Immunology (2023) IF: 7.3Products Cited: ARPE-19 Cells Line, C918 Cells Line -
Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinoma (2023-02-03)
Journal: Frontiers in Immunology (2023) IF: 7.3Products Cited: CFPAC-1 Cells Line, CFPAC-1 Cells Complete Medium -
Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager (2023-04-11)
Journal: Frontiers in Immunology (2023) IF: 7.3Products Cited: U266 [U266B1] Cells Line -
Expression of HSPA14 in patients with acute HIV-1 infection and its effect on HIV-1 replication (2023-02-09)
Journal: Frontiers in Immunology (2023) IF: 7.3Products Cited: CCRF-CEM [CCRF CEM] Cells Line, Jurkat, Clone E6-1 Cells Line, 293T [HEK-293T] Cells Line -
Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification (2023-03-15)
Journal: Frontiers in Immunology (2023) IF: 7.3Products Cited: STR Identification -
DDX58 expression promotes inflammation and growth arrest in Sertoli cells by stabilizing p65 mRNA in patients with Sertoli cell-only syndrome (2023-03-22)
Journal: Frontiers in Immunology (2023) IF: 7.3Products Cited: TM4 Cells Line, TM4 Cells Complete Medium -
A degradome-based prognostic signature that correlates with immune infiltration and tumor mutation burden in breast cancer (2023-03-13)
Journal: Frontiers in Immunology (2023) IF: 7.3Products Cited: MCF7 [MCF-7] Cells Line, MDA-MB-453S Cells Line -
The necroptosis related gene LGALS3 can be used as a biomarker for the adverse progression from chronic HBV infection to HCC (2023-04-26)
Journal: Frontiers in Immunology (2023) IF: 7.3Products Cited: Hep G2 Cells Line, HuH-7 Cells Line -
Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer (2023-03-03)
Journal: Frontiers in Immunology (2023) IF: 7.3Products Cited: GES-1 Cells Line, AGS Cells Line, HGC-27 Cells Line, KATO III [KATO 3] Cells Line, MKN-45 Cells Line
